Uterine Cancer Can be Cured
Uterine cancer is the most common female genital malignancy of the female reproductive tract accounted for 20 to 30% in recent years, the incidence of endometrial cancer, a clear upward trend.
The incidence of endometrial cancer and the continuing role of estrogen has a direct relationship between long periods of ovulation is the main cause of endometrial cancer risk factors. Estrogen can cause endometrial hyperplasia, as well as atypical hyperplasia, occurrence of endometrial cancer and thus, atypical hyperplasia of cancer is about 10 ~ 25% chance. Infertility, overweight, and late menopause occurs at age 52 the risk of endometrial cancer is fertility, normal body weight, menopause is less than 49 years of age to 5 times.
Endometrial cancer can occur at any age, but is essentially a cancer of older women, according to the U.S. in 1996, cancer registration statistics, the high incidence of the disease aged 58 to 61 years. Various types of uterine bleeding is the most prominent symptoms of the disease, about 50 to 70% of patients disease in postmenopausal women after menopause are not as manifested by the amount of irregular bleeding or increased menstruation. Therefore, irregular vaginal bleeding in older women endometrial cancer may be a signal, which should be a high degree of vigilance, and for younger patients, can not be taken lightly.
By curettage to obtain endometrial biopsy is the main method of diagnosis of the disease in recent years, the increasing use of hysteroscopy in clinical greatly increased rate of early diagnosis of endometrial cancer.
In addition, vaginal B-, lymphography, CT, MRI, and other serum tumor markers for the diagnosis and treatment in policy-making has some help.
Surgery is the primary treatment of endometrial cancer means the primary purpose of surgery to remove the tumor, the patient to conduct a comprehensive surgery – staging, choice of treatment modalities and prognosis. The scope of surgery according to patient’s age, in general, tumor growth, involving the range, and different pathological type and grade, even with advanced or recurrent cases, for the right patient, at the appropriate radiotherapy, hormone therapy or pelvic adjuvant therapy intervention may be considered after surgery. According to pathological risk factors after taking the appropriate adjuvant therapy.
As the slow growth of endometrial cancer, the transfer of late symptoms was significantly more prone to early detection, the treatment effect is better, the overall prognosis is better than other genital malignancies, 5-year survival rate of 60 to 70%, while the Phase Ⅰ 5-year survival rate of 90%, as long as active treatment with a doctor, early endometrial cancer can be cured.